Page last updated: 2024-09-02

tadalafil and bay 63-2521

tadalafil has been researched along with bay 63-2521 in 2 studies

Compound Research Comparison

Studies
(tadalafil)
Trials
(tadalafil)
Recent Studies (post-2010)
(tadalafil)
Studies
(bay 63-2521)
Trials
(bay 63-2521)
Recent Studies (post-2010) (bay 63-2521)
1,7423921,08925447238

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Thenappan, T; Weir, EK1
Chang, M; Gall, H; Grünig, E; Halank, M; Mielniczuk, L; Orozco-Levi, M; Tanabe, N; Vachiéry, JL; Vogtländer, K1

Other Studies

2 other study(ies) available for tadalafil and bay 63-2521

ArticleYear
The Nitric Oxide Pathway-A Potential Target for Precision Medicine in Pulmonary Arterial Hypertension.
    The American journal of cardiology, 2017, 10-15, Volume: 120, Issue:8S

    Topics: Cyclic GMP; Drug Therapy, Combination; Endothelins; Enzyme Activators; Humans; Hypertension, Pulmonary; Molecular Targeted Therapy; Nitric Oxide; Phosphodiesterase 5 Inhibitors; Precision Medicine; Pyrazoles; Pyrimidines; Signal Transduction; Sildenafil Citrate; Tadalafil

2017
Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH.
    Lung, 2018, Volume: 196, Issue:3

    Topics: Aged; Aged, 80 and over; Chronic Disease; Drug Substitution; Enzyme Activators; Female; Humans; Hypertension, Pulmonary; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Pulmonary Embolism; Pyrazoles; Pyrimidines; Retrospective Studies; Sildenafil Citrate; Tadalafil

2018